Choose License Type
The global rapid influenza diagnostics market is anticipated to grow on account of growing prevalence of influenza coupled with rising awareness across the developed and emerging economies. In the near future, an increase in influenza awareness, especially in developed regions, would fuel global market growth. The growth of the industry will be boosted by expanded healthcare investment based on R&D for influenza detection and therapeutics. The growth of the global rapid influenza diagnostics market will be boosted by increasing awareness towards rapid influenza diagnostic tests due to several benefits, such as disease specificity & quick findings. However, the lack of trained healthcare practitioners along with many influenza virus-related mutations will hinder the market development of rapid influenza diagnostic tests over the projected timeframe.
The global rapid influenza diagnostics market is categorized based on product, and end-use. Region wise, North America was the largest market in 2019; however, Asia Pacific is expected to be the fastest growing region by 2028 owing to growing government initiatives to tackle the outbreak of influenza. Factors that are catapulting demand growth are supposed to be the introduction of digital technologies and growing recognition among people. Asian countries are strongly engaged in taking protective steps to tackle the outbreak of the disease and there is raising concern. All these factors are projected to fuel demand for rapid influenza diagnostics market across the region
Key segments of the global rapid influenza diagnostics market
Product Overview, 2018-2028 (USD Million)
End-Use Overview, 2018-2028 (USD Million)
Regional Overview, 2018-2028 (USD Million)
Important Companies in Global Rapid Influenza Diagnostics Market
Reasons for the study
What does the report include?
Who should buy this report?
The global rapid influenza diagnostics market is anticipated to grow on account of growing prevalence of influenza coupled with rising awareness across the developed and emerging economies. In the near future, an increase in influenza awareness, especially in developed regions, would fuel global market growth. The growth of the industry will be boosted by expanded healthcare investment based on R&D for influenza detection and therapeutics. The growth of the global rapid influenza diagnostics market will be boosted by increasing awareness towards rapid influenza diagnostic tests due to several benefits, such as disease specificity & quick findings. However, the lack of trained healthcare practitioners along with many influenza virus-related mutations will hinder the market development of rapid influenza diagnostic tests over the projected timeframe.
The global rapid influenza diagnostics market is categorized based on product, and end-use. Region wise, North America was the largest market in 2019; however, Asia Pacific is expected to be the fastest growing region by 2028 owing to growing government initiatives to tackle the outbreak of influenza. Factors that are catapulting demand growth are supposed to be the introduction of digital technologies and growing recognition among people. Asian countries are strongly engaged in taking protective steps to tackle the outbreak of the disease and there is raising concern. All these factors are projected to fuel demand for rapid influenza diagnostics market across the region
Key segments of the global rapid influenza diagnostics market
Product Overview, 2018-2028 (USD Million)
End-Use Overview, 2018-2028 (USD Million)
Regional Overview, 2018-2028 (USD Million)
Important Companies in Global Rapid Influenza Diagnostics Market
Reasons for the study
What does the report include?
Who should buy this report?
Chapter 1. Introduction
1.1. Introduction to the Study
1.2. Market Definition and Scope
1.3. Units, Currency, Conversions and Years Considered
1.4. Key Stakeholders
1.5. Key Questions Answered
Chapter 2. Research Methodology
2.1. Introduction
2.2. Data Capture Sources
2.3. Primary Sources
2.4. Secondary Sources
2.5. Market Size Estimation
2.6. Market Forecast
2.7. Data Triangulation
2.8. Assumptions and Limitations
Chapter 3. Market Outlook
3.1. Introduction
3.2. Macroeconomic Indicators
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints
3.3.3. Opportunities
3.3.4. Challenges
3.4. Porter’s Five Forces Analysis
3.5. PESTLE Analysis
3.6. COVID-19 Impact Analysis
Chapter 4. Global Rapid Influenza Diagnostics Market by Product, 2018-2028 (USD Million)
4.1.1. RIDT for Influenza A
4.1.2. RIDT for Influenza B
Chapter 5. Global Rapid Influenza Diagnostics Market by End-Use, 2018-2028 (USD Million)
5.1.1. Hospitals
5.1.2. Diagnostics Centers
5.1.3. Research Laboratories
Chapter 6. Global Rapid Influenza Diagnostics Market by Region, 2018-2028 (USD Million)
6.1. North America
6.1.1. U.S.
6.1.2. Canada
6.2. Europe
6.2.1. Germany
6.2.2. UK
6.2.3. France
6.2.4. Spain
6.2.5. Rest of Europe
6.3. Asia Pacific
6.3.1. Japan
6.3.2. China
6.3.3. India
6.3.4. Rest of Asia Pacific
6.4. South America
6.4.1. Brazil
6.4.2. Mexico
6.4.3. Rest of South America
6.5. Middle East and Africa
6.5.1. GCC
6.5.2. South Africa
6.5.3. Rest of Middle East and Africa
Chapter 7. Competitive Landscape
7.1. Company Positioning
7.2. Strategic Initiatives
7.2.1. Mergers & Acquisitions
7.2.2. New Product Launch
7.2.3. Investments
7.2.4. Expansion
7.2.5. Others
Chapter 8. Company Profiles
8.1. DiaSorin Molecular LLC
8.2. BD
8.3. SA Scientific
8.4. Coris BioConcept
8.5. Meridian Bioscience Inc.
8.6. Abbott
8.7. Analytik Jena
8.8. F. Hoffmann-La Roche Ltd
8.9. Quidel Corporation
8.10. Princeton BioMeditech Corporation
Chapter 9. Appendix
9.1. Primary Research Approach
9.1.1. Primary Interview Participants
9.1.2. Primary Interview Summary
9.2. Questionnaire
9.3. Related Reports
9.3.1. Published
9.3.2. Upcoming